Ampersand Capital Partners has announced it has closed its latest fund, Ampersand 2022, with $1.2 billion in capital commitments.
The fund, the firm’s eleventh primary fund since 1992, was oversubscribed.
Ampersand, based in Wellesley, Mass., is a middle market
Continue Reading Ampersand Capital Closes New Fund With $1.2 Billion
Avista Capital Partners has acquired WellSpring Consumer Healthcare from Audax Private Equity, according to a news release.
WellSpring, founded in 1999 and based in Sarasota, Fla., markets over-the-counter drug and personal care products to the U.S. and Canadian
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires WellSpring Consumer From Audax
Arsenal Capital Partners has announced that it has completed fundraising for two new funds, totaling $5.4 billion in capital commitments.
Arsenal Capital Partners VI (Fund VI) closed with $4.3 billion in capital commitments. This exceeded its $3.0 billion target. The
Continue Reading Arsenal Capital Closes Two Funds With $5.4 Billion
Bow River Capital Partners has announced it has closed its third private equity fund at $590 million.
The fund was oversubscribed, exceeding its target of $500 million.
The new fund will continue the firm’s strategy of investing in middle market
Continue Reading Bow River Closes Third Private Equity Fund With $590 Million
WindRose Health Investors has announced it has completed a strategic investment in BPD (Brown Parker & DeMarinis).
BPD, founded in 2002 and based in Boca Raton, Fla., is a marketing services agency representing hospitals and health systems across the
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Invests in BPD
Great Point Partners (GPP) has announced a growth investment in Ephicacy Consulting Group.
Ephicacy, based in Iselin, N.J., is a biometrics contract research organization. Founded in 2005, the company provides outsourced statistical programming, data management and “real-world” evidence analytics
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Invests in Ephicacy
Veritas Capital has acquired Coronis Health, according to Axios.
Coronis, based in Sykesville, Md., is a healthcare revenue cycle management company. Founded in 2015, the company plays across several industries, including pathology, behavioral health, hospitals, surgery centers and
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Veritas Capital Acquires Coronis Health
Norwest Equity Partners (NEP) has announced it has completed an investment in QTI Fibers.
QTI, based in Colfax, N.C., is a designer and manufacturer of technical fibers, fabrics and coatings for healthcare and other applications. Founded in 1922, QTI
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Norwest Invests in QTI Fibers
Ampersand Capital Partners has completed an investment in Sterling Medical Devices, according to a news release.
Sterling, based in Moonachie, N.J., is a provider of electromechanical and software solutions for the medical device industry. Founded in 1998, the
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Invests in Sterling Medical Devices
Linden Capital Partners has announced it will make a majority investment in Aspirion.
Aspirion, based in Columbus, Ga., is a full-service revenue cycle management company. Founded in 2006, the company specializes in motor vehicle accident, third-party liability, workers’ compensation,
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Linden to Acquire Aspirion